
VRDN News
Viridian Therapeutics, Inc.
$30.12
+$0.06(+0.20%)
59
Overall
60
Value
83
Tech
34
Quality
Market Cap
$3.42B
Volume
1.49M
52W Range
$13.18 - $34.29
Target Price
$42.06
VRDN news: the latest Viridian Therapeutics, Inc. headlines, press releases and market updates, newest first.
Latest VRDN News
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Viridian Therapeutics (VRDN), Editas Medicine (EDIT) and Praxis Precision Medicines (PRAX)TipRanks Newsroom · Nov 10, 2026
- Viridian Reports Positive Phase 1 Results for VRDN-008TipRanks Auto-Generated Newsdesk · Nov 9, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viridian Therapeutics (VRDN), Insulet (PODD) and BeOne Medicines (ONC)TipRanks Newsroom · Nov 6, 2026
- Analysts’ Top Healthcare Picks: Viridian Therapeutics (VRDN), Idexx Laboratories (IDXX)TipRanks Newsroom · Nov 4, 2026
- Viridian Metals Launches $5 Million Private Placement to Advance Kraken and Sedna ProjectsTipRanks Canadian Auto-Generated Newsdesk · Oct 29, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $30.12 | +0.2% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW